title: Tuberculosis complications after BCG treatment for urinary bladder cancer.
abstract: Bacillus Calmette-Guérin (BCG) is an attenuated strain of Mycobacterium bovis that has been effectively used in the treatment of non-muscle invasive bladder carcinoma. The complications of this treatment are uncommon, and the causes of dissemination are still discussed. We report a case of disseminated tuberculosis in a 66-year-old smoking man without a history of pulmonary diseases, who underwent immunotherapy with BCG after the initial surgical treatment of bladder cancer. After the last BCG instillation, he developed a fever. The diagnosis of sepsis was not confirmed, and miliary pulmonary tuberculosis was suspected. The diagnosis was confirmed by clinical manifestation, computed tomography of the lungs, and histological examination.
authors: Department of Internal Diseases, Medical Academy, Lithuanian University of Health Sciences, Eivenių 2, 50028 Kaunas, Lithuania.
authors: Albinas
authors: A
authors: Naudžiūnas
authors: Rūta
authors: R
authors: Juškaitė
authors: Indrė
authors: I
authors: Žiaugrytė
authors: Alvydas
authors: A
authors: Unikauskas
authors: Eglė
authors: E
authors: Varanauskienė
authors: Edita
authors: E
authors: Mašanauskienė
mesh_terms: D000368:Aged; D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects; D008297:Male; D014057:Tomography, X-Ray Computed; D014391:Tuberculosis, Miliary / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000209:etiology; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000209:etiology; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D001500:BCG Vaccine